Clinical Trials Directory

Trials / Unknown

UnknownNCT06062706

Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy

Comparison of Outcomes in Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy: A Single Center Prospective Registry Study

Status
Unknown
Phase
Study type
Observational
Enrollment
3,448 (estimated)
Sponsor
King Faisal Specialist Hospital & Research Center · Academic / Other
Sex
All
Age
1 Month – 75 Years
Healthy volunteers
Not accepted

Summary

This will be a study to examine the outcomes of open, laparoscopic, and robotic Living Donor Liver Transplantation (LDLT) procedures. The analysis will encompass 3,448 cases (1,724 donor-recipient pairs) from January 2011 to March 2023, documenting the transition between these surgical techniques, with a noted crossover in 2018.

Detailed description

Background: Liver transplantation is a primary treatment for end-stage liver disease, enhancing survival rates and life quality. Living donor liver transplantation (LDLT) has gained prominence due to the scarcity of deceased donor organs. Historically, the open technique dominated living donor hepatectomies. However, advances in minimally invasive surgery (MIS) led to laparoscopic and later robotic procedures. With the introduction of robotic surgery, MIS for complex surgeries improved, offering better precision and ergonomics. Objective: To compare the short and long-term outcomes of open, laparoscopic, and robotic LDLT, focusing on both donors and recipients. Methods: Study Design: Retrospective analysis of data from a prospective liver transplant registry, examining three LDLT techniques. Setting: King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Participants: All consecutive living donor and recipient pairs undergoing LDLT between January 2011 and March 2023. Exclusions include dual or domino LDLT. Surgical Techniques: Open, laparoscopic, and robotic techniques used for donor hepatectomies. Variables: Primary focus on morbidity, conversion rates, and in-hospital mortality for both donors and recipients. Secondary variables will include major complications, graft, and recipient survival rates. Data Sources and Measurement: Data sourced from a secured, encrypted transplant database, detailing patient data, operation characteristics, and post-op outcomes. Complication severity will be captured using the Clavien-Dindo classification and Comprehensive Complication Index™. Study Size: Determined by the total number of procedures during the study duration, deemed sufficient for comparison. Quantitative Variables: Demographics, comorbidities, operational details, post-op and long-term outcomes. Statistical Methods: Various statistical tests will be employed for comparison, including the Student t, Mann-Whitney U, one-way ANOVA, Fischer and Chi square. Survival will be evaluated using the Kaplan-Meier method. Multivariable binary logistic regression will be employed. All statistical analyses will be conducted using R. Ethics Approval: Obtained (ID: RAC 2121012) and in accordance with the 1964 Helsinki declaration.

Conditions

Interventions

TypeNameDescription
PROCEDUREDonor hepatectomyDonor hepatectomy is a surgical procedure to resect a portion of the liver from a living donor for transplantation. This usually involved the right lobe, the left lobe or the left lateral section of the liver. Depending on the surgical method, this can be achieved through open, laparoscopic, or robotic-assisted techniques. As for the recipient, liver transplantation involves a total hepatectomy of the diseased liver from the recipient and implantation of the liver graft from the donor. This is typically performed using the open surgical approach.

Timeline

Start date
2023-08-06
Primary completion
2023-10-15
Completion
2023-10-30
First posted
2023-10-02
Last updated
2023-10-02

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT06062706. Inclusion in this directory is not an endorsement.